Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
65 Results Found
Advocacy Issue: 340B Drug Pricing Program
The 340B program has worked successfully for over 30 years to allow eligible providers to stretch limited federal resources to provide more comprehensive programs and services to more patients. This is exactly what Congress intended when it created the program in 1992.
Chair File: Leadership Dialogue — Legal Advocacy to Protect Hospitals With AHA General Counsel Chad Golder
Chad Golder, general counsel at the AHA, recently joined me on the Leadership Dialogue for a conversation on our current legal environment, what the AHA is doing on behalf of members, and what hospital and health system leaders can do to help.
Chair File: The Importance of Legal Advocacy
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get the resources we need to care for our communities.
340B Advocacy Alliance Bulletin - June 13, 2025
AHA Post-Acute Care Advocacy Alliance News Update - June 13, 2025
340B Advocacy Alliance Bulletin - April 24, 2025
340B Advocacy Alliance Bulletin for April 24, 2025.
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Congressional committees have begun marking up their portions of a reconciliation bill to enact key pieces of President Trump’s agenda.
AHA 340B Advocacy Alliance Bulletin: HRSA Issues Final Warning to J&J on 340B Proposal
The Health Resources and Services Administration today sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month.
White House issues executive order on drug pricing
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
AHA 340B Advocacy Alliance
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.